Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM9VYOI)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
NSC648146; 1,2,5-Thiadiazolidin-3-one 1,1-dioxide; 1,1-dioxo-1,2,5-thiadiazolidin-3-one; AC1Q6H1D; SCHEMBL630051; CHEMBL1996483; CTK7H4434; AC1L8566; NSC-648146; NCI60_016689; 1,5-Thiadiazolidin-3-one, 1,1-dioxide; 1,2,5-thiadiazolidine-3-one-1,1-dioxide; 1,2,5-Thiadiazolidine-3-one 1,1-dioxide; 1,2,5-Thiadiazolidin-3-one, 1,1-dioxide
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||